These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19079235)

  • 1. Barrier dysfunction due to distinct defensin deficiencies in small intestinal and colonic Crohn's disease.
    Wehkamp J; Koslowski M; Wang G; Stange EF
    Mucosal Immunol; 2008 Nov; 1 Suppl 1():S67-74. PubMed ID: 19079235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defensin-immunology in inflammatory bowel disease.
    Wehkamp J; Stange EF; Fellermann K
    Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S137-44. PubMed ID: 20117337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease.
    Wehkamp J; Schmid M; Fellermann K; Stange EF
    J Leukoc Biol; 2005 Apr; 77(4):460-5. PubMed ID: 15618294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host-microbe interaction: mechanisms of defensin deficiency in Crohn's disease.
    Wang G; Stange EF; Wehkamp J
    Expert Rev Anti Infect Ther; 2007 Dec; 5(6):1049-57. PubMed ID: 18039087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new look at Crohn's disease: breakdown of the mucosal antibacterial defense.
    Wehkamp J; Stange EF
    Ann N Y Acad Sci; 2006 Aug; 1072():321-31. PubMed ID: 17057212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Paneth cell alpha-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4.
    Wehkamp J; Wang G; Kübler I; Nuding S; Gregorieff A; Schnabel A; Kays RJ; Fellermann K; Burk O; Schwab M; Clevers H; Bevins CL; Stange EF
    J Immunol; 2007 Sep; 179(5):3109-18. PubMed ID: 17709525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory bowel disease: an impaired barrier disease.
    Jäger S; Stange EF; Wehkamp J
    Langenbecks Arch Surg; 2013 Jan; 398(1):1-12. PubMed ID: 23160753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of defensins in the pathogenesis of chronic-inflammatory bowel disease].
    Schmid M; Fellermann K; Wehkamp J; Herrlinger K; Stange EF
    Z Gastroenterol; 2004 Apr; 42(4):333-8. PubMed ID: 15095125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human defensins in Crohn's disease.
    Wehkamp J; Fellermann K; Stange EF
    Chem Immunol Allergy; 2005; 86():42-54. PubMed ID: 15976487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced Paneth cell alpha-defensins in ileal Crohn's disease.
    Wehkamp J; Salzman NH; Porter E; Nuding S; Weichenthal M; Petras RE; Shen B; Schaeffeler E; Schwab M; Linzmeier R; Feathers RW; Chu H; Lima H; Fellermann K; Ganz T; Stange EF; Bevins CL
    Proc Natl Acad Sci U S A; 2005 Dec; 102(50):18129-34. PubMed ID: 16330776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-defensins in the gastrointestinal tract.
    Cunliffe RN
    Mol Immunol; 2003 Nov; 40(7):463-7. PubMed ID: 14568393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defensins and inflammation: the role of defensins in inflammatory bowel disease.
    Ramasundara M; Leach ST; Lemberg DA; Day AS
    J Gastroenterol Hepatol; 2009 Feb; 24(2):202-8. PubMed ID: 19215333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective paneth cell-mediated host defense in pediatric ileal Crohn's disease.
    Perminow G; Beisner J; Koslowski M; Lyckander LG; Stange E; Vatn MH; Wehkamp J
    Am J Gastroenterol; 2010 Feb; 105(2):452-9. PubMed ID: 19904243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression.
    Wehkamp J; Harder J; Weichenthal M; Schwab M; Schäffeler E; Schlee M; Herrlinger KR; Stallmach A; Noack F; Fritz P; Schröder JM; Bevins CL; Fellermann K; Stange EF
    Gut; 2004 Nov; 53(11):1658-64. PubMed ID: 15479689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crohn's disease: a defensin deficiency syndrome?
    Fellermann K; Wehkamp J; Herrlinger KR; Stange EF
    Eur J Gastroenterol Hepatol; 2003 Jun; 15(6):627-34. PubMed ID: 12840673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defensins and other antimicrobial peptides in inflammatory bowel disease.
    Wehkamp J; Schmid M; Stange EF
    Curr Opin Gastroenterol; 2007 Jul; 23(4):370-8. PubMed ID: 17545771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of a functional variant in the Wnt co-receptor LRP6 with early onset ileal Crohn's disease.
    Koslowski MJ; Teltschik Z; Beisner J; Schaeffeler E; Wang G; Kübler I; Gersemann M; Cooney R; Jewell D; Reinisch W; Vermeire S; Rutgeerts P; Schwab M; Stange EF; Wehkamp J
    PLoS Genet; 2012; 8(2):e1002523. PubMed ID: 22393312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crohn's disease--defect in innate defence.
    Gersemann M; Wehkamp J; Fellermann K; Stange EF
    World J Gastroenterol; 2008 Sep; 14(36):5499-503. PubMed ID: 18810765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Barrier- and autophagic functions of the intestinal epithelia: role of disturbances in the pathogenesis of Crohn's disease].
    Lapis K
    Orv Hetil; 2010 Oct; 151(40):1645-55. PubMed ID: 20860961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Interplay between Defensins and Microbiota in Crohn's Disease.
    Coretti L; Natale A; Cuomo M; Florio E; Keller S; Lembo F; Chiariotti L; Pero R
    Mediators Inflamm; 2017; 2017():8392523. PubMed ID: 28246439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.